Trial Identifier: | D5980R00033 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05219630 |
Start Date: | May 2022 |
Primary Completion Date: | May 2023 |
Study Completion Date: | May 2023 |
Condition: | Chronic Obstructive Pulmonary Disease (COPD) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |
Japan, Kagawa | Takamatsu, Kagawa, Japan |